Natural Product Discovery from Rare Actinomycetes

Rare actinomycetes encompass under-explored members of the Actinobacteria phylum which, despite low isolation frequency, possess immense biosynthetic potential. Advances in cultivation techniques, including tailored media formulations, microfluidic trapping and co-cultivation, have expanded access to these elusive taxa. Concurrently, genomic sequencing and bioinformatics have unveiled vast repertoires of cryptic biosynthetic gene clusters (BGCs), many of which remain silent under standard laboratory conditions. Activation strategies—such as heterologous expression, promoter engineering and chemical elicitation—have begun to unlock novel secondary metabolites. These compounds span diverse structural classes, including polyketides, nonribosomal peptides and terpenoids, and exhibit potent antibacterial, antifungal, antiviral and anticancer activities. Global interest is driven by urgent needs for new antibiotics to combat resistance, as well as antivirals and immunomodulators. Integration of metabolomics, synthetic biology and machine learning promises to accelerate discovery, while ecological and biogeographical surveys continue to identify unique habitats—such as deep-sea sediments, deserts and mangrove rhizospheres—as reservoirs of rare actinomycetes. Together, these multidisciplinary efforts are reshaping the landscape of natural product research and opening routes to future therapeutics.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Natural Product Discovery from Rare Actinomycetes publication trend

The graph below shows the total number of articles in natural product discovery from rare actinomycetes across all publications each year (not limited to Nature Index journals).

Technical terms

rare actinomycetes: Actinobacteria taxa that are infrequently isolated but often harbour unique biosynthetic capacities.

secondary metabolite: A low-molecular-weight compound produced by microorganisms that is not essential for growth but may confer ecological advantages and therapeutic potential.

biosynthetic gene cluster (BGC): A contiguous set of genes encoding enzymes and regulatory elements required for the biosynthesis of a specific secondary metabolite.

genome mining: The computational analysis of genomic data to predict and prioritise BGCs for novel natural product discovery.

silent gene cluster: A BGC that remains unexpressed under standard cultivation conditions and requires targeted activation to yield its metabolite.

sesquarterpenoid: A rare terpenoid class characterised by a C35 carbon framework, often bearing unusual ring systems and functional groups.

References

1. Persicamidines—Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses. Angewandte Chemie International Edition (2023).
2. New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived Micromonospora Strains. Marine Drugs (2023).
3. In Silico Analysis of PKS and NRPS Gene Clusters in Arisostatin- and Kosinostatin-Producers and Description of Micromonospora okii sp. nov.. Antibiotics (2021).